Your browser version may not work well with NCBI's Web applications. More information
here...
-
Medications do not necessarily normalize cognition in ADHD patients.
North Carolina Neuropsychiatry Clinics, Chapel Hill, NC 27514, USA. tg@ncneuropsych.com
OBJECTIVE: Although ADHD medications are effective for the behavioral components of the disorder, little information exists concerning their effects on cognition, especially in community samples. METHOD: A cross-sectional study of ADHD patients treated with three different ADHD drugs was conducted. Patients' performance on a computerized neurocognitive screening battery was compared to untreated ADHD patients and normal controls (NML). A total of 177 ADHD patients aged 10 to 18, achieved a favorable response to one of the following medications: Adderall XR (AMP), atomoxetine (ATMX), and Concerta (MPH-OROS) compared to 95 untreated ADHD patients and 101 NML. RESULTS: Significant differences were detected between normals and untreated ADHD patients. Treated patients performed better than untreated patients but remained significantly impaired compared to normal subjects. CONCLUSION: Even with optimal treatment, based on parents' and teachers' opinions, subtle and not-so-subtle neurocognitive impairments persisted in the ADHD patients. Some ADHD patients may require additional educational assistance, even in the face of successful medication treatment.
PMID: 17934180 [PubMed - indexed for MEDLINE]
-
Related Articles
-
Patient Drug Information
-
Methylphenidate (Concerta®, Metadate®, Methylin®, ...)
Methylphenidate is used as part of a treatment program for attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same ag...
-
Atomoxetine (Strattera®)
Atomoxetine is used as part of a total treatment program to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children and adults with ADHD. Atomoxetine is in a class of medications ca...